Dr Kim Lorenzen, MD | |
525 N Foster St, Mitchell, SD 57301-2966 | |
(605) 995-2343 | |
Not Available |
Full Name | Dr Kim Lorenzen |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 525 N Foster St, Mitchell, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740286285 | NPI | - | NPPES |
399365500 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 2700 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kim Lorenzen, MD 525 N Foster St, Mitchell, SD 57301-2966 Ph: (605) 995-2343 | Dr Kim Lorenzen, MD 525 N Foster St, Mitchell, SD 57301-2966 Ph: (605) 995-2343 |
News Archive
Amgen Inc., the world's largest biotechnology company, and Tularik Inc., a pioneer in drug discovery related to cell signaling and the control of gene expression, today jointly announced that they have signed a definitive merger agreement whereby Tularik will become a wholly-owned subsidiary of Amgen in a stock for stock transaction.
Kaiser Health News provides a fresh perspective on health policy developments with "Great Pumpkin" by Lisa Benson.
The UK's National Physical Laboratory with the University of Edinburgh and IBM's TJ Watson Research Center have published new research about the structure of an HIV-1 protein that could help to develop new drugs to stop the virus infecting healthy cells.
Over the next 20 years, "[c]limate change is likely to spread malaria to new areas in the Indian Himalayas, and lengthen the periods in which the infection is spread in a number of districts, according to projections [.pdf] from" researchers at the National Institute of Malaria Research (NIMR), Delhi, and published in a special issue of Current Science on Wednesday, SciDev.Net reports.
› Verified 3 days ago